Fluorise T Eye Drop contains Tobramycin 0.3% w/v + Fluorometholone 0.1% w/v, a dual-action ophthalmic formulation designed to treat bacterial eye infections while controlling associated inflammation. Its combination ensures rapid infection management with steroidal symptom relief.
Tobramycin works by inhibiting bacterial protein synthesis, effectively eliminating susceptible ocular pathogens, while Fluorometholone reduces inflammation, redness, and discomfort, supporting faster recovery.
From a commercial perspective, Fluorise T Eye Drop is a widely prescribed ophthalmic steroid-antibiotic combination, suitable for eye clinics, hospitals, and post-operative care, ensuring consistent demand and repeat prescriptions.
Including Fluorise T Eye Drop in your portfolio strengthens the ophthalmic steroid-antibiotic segment, providing long-term business growth, high prescriber confidence, and enhanced portfolio credibility for PCD pharma franchise partners.
Common side effects may include mild stinging or burning sensation, temporary blurred vision, eye irritation, or dryness. Rarely, prolonged use may lead to increased intraocular pressure, cataract formation, secondary eye infections, or allergic reactions to Tobramycin.
Fluorise T Eye Drop is indicated for the treatment of ocular inflammatory conditions with bacterial involvement, such as conjunctivitis, keratitis, and post-operative eye inflammation. Use is recommended under the supervision of an ophthalmologist.
Use Fluorise T Eye Drop strictly as prescribed by an ophthalmologist. Avoid touching the dropper tip to the eye to prevent contamination. Do not use for extended periods without medical supervision. Discontinue and consult a doctor if severe irritation, vision changes, or signs of infection occur.
Store in a cool, dry place below 25 °C. Protect from direct sunlight, keep the bottle tightly closed, and out of reach of children. Do not use beyond the expiry date.